Evidence map›Paper›PMID 19325784›Full record

ArticleInternational journal of molecular sciences2008

Sublethal RNA oxidation as a mechanism for neurodegenerative disease.

Rudy J Castellani, Akihiko Nunomura, Raj K Rolston, Paula I Moreira, Atsushi Takeda, George Perry, Mark A Smith

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04287543 (Effect of Melatonin Administration on the PER1 and BMAL1 Clock Genes in Patients With Parkinson's Disease), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04287543 phase2 / phase3withdrawnnot on this mapstarted 2021, after this paper: background citation

Effect of Melatonin Administration on the PER1 and BMAL1 Clock Genes in Patients With Parkinson's Disease

TypeinterventionalSponsorInstituto Mexicano del Seguro SocialRan2021 to 2022Enrolled0ConditionsParkinson DiseaseArmsMelatonin, Placebos
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Tau Oligomers Neurotoxicity.Life (Basel, Switzerland) · 2021
    Review
  6. Role of RNA Oxidation in Neurodegenerative Diseases.International journal of molecular sciences · 2020
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Diabetes and the brain: oxidative stress, inflammation, and autophagy.Oxidative medicine and cellular longevity · 2014 · on this map
    Review
  12. Oxidative stress and neurodegenerative disorders.International journal of molecular sciences · 2013
    Review
  13. Review
  14. A novel origin for granulovacuolar degeneration in aging and Alzheimer's disease: parallels to stress granules.Laboratory investigation; a journal of technical methods and pathology · 2011
    Article
  15. tRNA structural and functional changes induced by oxidative stress.Cellular and molecular life sciences : CMLS · 2011
    Review
  16. Article
  17. Article
  18. Basic mechanisms of neurodegeneration: a critical update.Journal of cellular and molecular medicine · 2010
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Rudy J CastellaniDepartment of Pathology, University of Maryland, Baltimore, Maryland, USA.
Akihiko NunomuraDepartment of Neuropsychiatry, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Yamanashi, Japan.
Raj K RolstonDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Paula I MoreiraDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Atsushi TakedaDepartment of Neurology, Tohoku University School of Medicine, Sendai, Japan.
George PerryDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.ORCID 0000-0002-6547-0172
Mark A SmithDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Case Western Reserve University · USThe University of Texas at San Antonio · USTohoku University · JPUniversity of Maryland, Baltimore · USUniversity of Yamanashi · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although cellular RNA is subjected to the same oxidative insults as DNA and other cellular macromolecules, oxidative damage to RNA has not been a major focus in investigations of the biological consequences of free radical damage. In fact, because it is largely single-stranded and its bases lack the protection of hydrogen bonding and binding by specific proteins, RNA may be more susceptible to oxidative insults than is DNA. Oxidative damage to protein-coding RNA or non-coding RNA will, in turn, potentially cause errors in proteins and/or dysregulation of gene expression. While less lethal than mutations in the genome, such sublethal insults to cells might be associated with underlying mechanisms of several chronic diseases, including neurodegenerative disease. Recently, oxidative RNA damage has been described in several neurodegenerative diseases including Alzheimer disease, Parkinson disease, dementia with Lewy bodies, and prion diseases. Of particular interest, oxidative RNA damage can be demonstrated in vulnerable neurons early in disease, suggesting that RNA oxidation may actively contribute to the onset of the disease. An increasing body of evidence suggests that, mechanistically speaking, the detrimental effects of oxidative RNA damage to protein synthesis are attenuated, at least in part, by the existence of protective mechanisms that prevent the incorporation of the damaged ribonucleotides into the translational machinery. Further investigations aimed at understanding the processing mechanisms related to oxidative RNA damage and its consequences may provide significant insights into the pathogenesis of neurodegenerative and other degenerative diseases and lead to better therapeutic strategies.

Indexed as

8-oxoguanosineAlzheimer diseaseneurodegenerationoxidative damageParkinson diseaseRNA

Identifiers

PMID19325784
PMCPMC2635712
OpenAlexW2023005077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.